Protective effect of probiotics against acetaminophen induced nephrotoxicity.

Tarun Kumar Dua, Sangita Palai, Abani Roy, Paramita Paul

Journal: Molecular biology reports 2022;49(8):8139-8143

PMID: 35661049

Abstract

Acetaminophen (APAP) is commonly prescribed as an antipyretic and analgesic agent in the practical field. Like every other drug(s), APAP also undergo metabolism by oxidation or conjugation by glucuronate and sulphate to form the toxic metabolite N-acetyl-p-benzoquinone imine (NAPQI). Moreover, the NAPQI is detoxified by conjugation with reduced glutathione (GSH). Interestingly, APAP is also metabolized in the kidney by deacetylation reaction in the presence of N-deacetylase enzyme into another severely toxic but minor metabolite, p-aminophenol. Both NAPQI and p-aminophenol shows nephrotoxicity as well as hepatotoxicity. Hence, the long-term therapeutic dose use and unnecessary overdose of APAP are of great concern as prolonged negligence may cost the nephrotoxicity that may lead to uremia and finally to kidney failure. It has recently been investigated that probiotic supplementation inhibits the sequential events associated with APAP-induced nephrotoxicity. This review emphasizes the role of different probiotics that have already been investigated in nephrotoxicity or uremia caused by APAP overdose.

© 2022. The Author(s), under exclusive licence to Springer Nature B.V.

Address: Department of Pharmaceutical Technology, University of North Bengal, Raja Rammohunpur, 734013, Darjeeling, West Bengal, India. [email protected].; Department of Pharmaceutical Technology, University of North Bengal, Raja Rammohunpur, 734013, Darjeeling, West Bengal, India.

Link outs

Subscription / membership required

Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.